About DMD Partners Canada
Technology
Making state-of-the-art technology attainable, improve human health.
DMD believes that technology is the key to decode the secret of human body.
Future
Focus on future health trends, create flagship products, brands and ecology that lead the era.
Integration
Redefine medical research and products development by incorporating Artificial Intelligence.
Headquartered in Vancouver, Canada, DMD Partners is an integrated medical and health product provider. The company’s business revolves around the application of Artificial Intelligence and Big Data in the fields of biomedicine and general wellness. The in-house database and Artificial Intelligence of our R&D Center provide optimal solutions for our private brands and cooperative brands.
On this basis, DMD has a global perspective and is committed to the rapid transformation of medical technology achievements into practical applications. We continue to pay attention to and invest in innovative projects at the forefront of medical technology. We empower these projects to complete the entire circle of integrating upstream and downstream, supply chains, corporate financial and capital utilization, and blockchain.
About UltralSpec Lab
DMD R&D centre is committed to integrating AI (artificial intelligence) and biochemical technology to develop pharmaceutical formulations and wellness products. In recent years, the laboratory has made a lot of breakthroughs in academic research, product development and project implementation.
UltraSpec Lab is closely working with the Canadian Information Technology and Comprehensive Systems Mathematical Organization (Mitacs) and the University of Victoria in biomedical diagnosis, material metabolism simulation, artificial intelligence drug development and other projects. Additionally, UltraSpec Lab has achieved great success in the implementation of the NMN (β-nicotinamide mononucleotide) cell repair supplement project, the development of AI prescriptions and the simulation of efficacy (the development of prescription drugs such as cannabidiol).
* The background image is a visualization of UltraSpec Lab cellular data simulations, with each line representing a human physiological response.
Please click the button below to visit the UltralSpec Lab official website.
What do we do?
DMD’s business revolves around the mission of ” Focus on future health trends, elevate the welfare of everyone of us”. We believe that the future of healthy life should be composed of daily health management and emerging medical technology, which also derives two major business segments of DMD: wellness products incubation and pharmaceutical development.
The incubation of wellness products is based on health food, nutritional supplements and customized health services oriented to benefit all. It aims to improve the quality of life and meet our daily demand of health management with cutting-edge technology. By doing so, we will make natural and healthy lifestyle a new norm.
The pharmaceutical development business segment focuses on more targeted OTC and prescription drug development. DMD’s in-house technology enhances the safety and effectiveness of drugs in all dimensions, and shortens the development time of new drugs to a large extent. Our exclusive advantages, such as in-house Artificial Intelligence and databases, breaks through the existing logic and process of traditional medicine development. Thus, the gospel of science and technology can benefit everyone of us more widely and conveniently.
DMD’s business revolves around the mission of ” Focus on future health trends, elevate the welfare of everyone of us”. We believe that the future of healthy life should be composed of daily health management and emerging medical technology, which also derives two major business segments of DMD: wellness products incubation and pharmaceutical development.
The incubation of wellness products is based on health food, nutritional supplements and customized health services oriented to benefit all. It aims to improve the quality of life and meet our daily demand of health management with cutting-edge technology. By doing so, we will make natural and healthy lifestyle a new norm.
The pharmaceutical development business segment focuses on more targeted OTC and prescription drug development. DMD’s in-house technology enhances the safety and effectiveness of drugs in all dimensions, and shortens the development time of new drugs to a large extent. Our exclusive advantages, such as in-house Artificial Intelligence and databases, breaks through the existing logic and process of traditional medicine development. Thus, the gospel of science and technology can benefit everyone of us more widely and conveniently.